Medication to Manage Abortion and Miscarriage.

Area of Science:

• Reproductive Health
• Pharmacology

Background:

• Abortion and miscarriage are highly prevalent in the US, impacting millions of women annually.
• Medication abortion and miscarriage management often utilize the same medication regimen: mifepristone followed by misoprostol.
• These treatments are safe and effective before 10-13 weeks of gestation and can be administered in outpatient settings.

Purpose of the Study:

• To review current evidence on mifepristone and misoprostol for early abortion and miscarriage.
• To provide guidance for primary care providers integrating these medications into practice.
• To highlight the role of general internists in expanding access to reproductive health services.

Main Methods:

• Literature review of recent evidence on medication abortion and miscarriage management.
• Discussion of clinical considerations for prescribing mifepristone and misoprostol.
• Identification of resources for healthcare providers.

Main Results:

• Mifepristone and misoprostol are safe and effective for medication abortion and miscarriage management.
• These medications can be safely used in ambulatory settings without specialized equipment.
• Primary care integration of these medications can improve access to time-sensitive care.

Conclusions:

• General internists and primary care providers are crucial for managing early abortion and miscarriage.
• Familiarity with mifepristone and misoprostol regimens enhances clinical practice.
• Expanding prescribing capabilities improves access to essential reproductive health services for vulnerable populations.